202
Participants
Start Date
July 29, 2020
Primary Completion Date
April 26, 2021
Study Completion Date
April 26, 2021
Trifarotene cream
Trifarotene 50 mcg/g cream applied topically once daily on face for 12 weeks.
Doxycycline hyclate
Doxycycline hyclate delayed release 120 mg tablets was administered orally for 12 weeks.
Trifarotene Vehicle
Trifarotene 50 mcg/g vehicle cream was applied topically once daily on face for 12 weeks.
Doxycycline Placebo
Doxycycline hyclate delayed release 120 mg placebo tablets was administered orally for 12 weeks.
Galderma Investigational Site, Aibonito
Galderma Investigational Site, Stony Brook
Galderma Investigational Site, Sugarloaf
Galderma Investigational Site, Rockville
Galderma Investigational Site, High Point
Galderma Investigational Site, Newnan
Galderma Investigational Site, Miramar
Galderma Investigational Site, Aventura
Galderma Investigational Site, Boca Raton
Galderma Investigational Site, Knoxville
Galderma Investigational Site, New Albany
Galderma Investigational Site, Evansville
Galderma Investigational Site, Warren
Galderma Investigational Site, New Brighton
Galderma Investigational Site, Hot Springs
Galderma Investigational Site, Charleston
Galderma Investigational Site, Rogers
Galderma Investigational Site, Fort Smith
Galderma Investigational Site, Dallas
Galderma Investigational Site, Arlington
Galderma Investigational Site, Grapevine
Galderma Investigational Site, San Antonio
Galderma Investigational Site, San Antonio
Galderma Investigational Site, Pflugerville
Galderma Investigational Site, Las Vegas
Galderma Investigational Site, Newport Beach
Lead Sponsor
Galderma R&D
INDUSTRY